דוגמאות למימון של מחקרים
EPIC-Oxford: Supported by the Cancer Research UK, Medical Research Council.
AHS-2: This study was funded as part of the NIH, the USDA, and the WCRF.
SMHS: This work was funded by National Cancer Institute grants (R37CA070867, PI: WZ; R01 CA082729, PI: XOS) and the National Heart, Lung, and Blood Institute (R0 1HL095931, PI: XZ).
AARP: This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute.
MEC: This work was supported by the U.S. National Cancer Institute (Grant Number R37 CA54821) and the U.S. Department of Agriculture (USDA-NRI New Investigator Award, Grant Number 2002-00793).
NHS: This study was supported by grants DK58845, CA55075, CA87969, HL34594, and 1U54CA155626-01 from the National Institutes of Health
and by career development award K99HL098459 from the National Heart, Lung, and Blood Institute (Dr Sun).
למחקר EPIC יש רשימת מממנים ארוכה:
The work described in this article was carried out with the financial support
of Europe Against Cancer Program of the European Commission (SANCO);
Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal
Ministry of Education and Research; Danish Cancer Society; Health Research
Fund (FIS) of the Spanish Ministry of Health, Spanish Regional Governments
of Andalucia, Asturias, Basque Country, Murcia and Navarra; ISCIII RCESP exp.
C03/09, Spain; Cancer Research UK; Medical Research Council, United
Kingdom; Stroke Association, United Kingdom; British Heart Foundation;
Department of Health, United Kingdom; Food Standards Agency, United
Kingdom; Wellcome Trust, United Kingdom; the Hellenic Health Foundation
and the Stavros Niarchos Foundation; Italian Association for Research on
Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco
Napoli, Italy; Dutch Ministry of Public Health, Welfare and Sports (VWS),
Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention
Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research
Fund (WCRF), Statistics Netherlands (The Netherlands); Swedish Cancer
Society; Swedish Scientific Council; Regional Government of Skåne, Sweden;
Nordforsk the Norwegian Cancer Society; French League against Cancer
(LNCC); National Institute for Health and Medical Research (INSERM), France;
Mutuelle Générale de l'Education Nationale (MGEN), France; 3M Co, France;
Gustave Roussy Institute (IGR), France; and General Councils of France.
The sponsors had no input in the design, conduct, analysis, or interpretation
of the study, and did not influence manuscript preparation.